Technical Analysis for ATH - Alterity Therapeutics Limited

Grade Last Price % Change Price Change
C 0.004 -11.11% -0.001
ATH closed up 12.5 percent on Monday, March 18, 2024, on 7 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish -11.11%
180 Bullish Setup Bullish Swing Setup -11.11%
Wide Bands Range Expansion -11.11%
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Wide Bands Range Expansion 0.00%

   Recent Intraday Alerts

Alert Time
Down 10% about 2 hours ago
Gap Up Closed about 2 hours ago
Upper Bollinger Band Resistance about 2 hours ago
Reversed from Up about 2 hours ago
50 DMA Resistance about 2 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Alterity Therapeutics Limited Description

Alterity Therapeutics Limited, formerly Prana Biotechnology Limited, is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. The Company's lead product candidates are PBT2 and PBT434. The Company's lead drug candidate PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. The Company also has advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Its other applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease), and a range of orphan neurodegenerative disorders.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Cancer Diseases Drugs Biology Cancers Disorders Geriatrics Neuroscience Psychiatric Diagnosis Alzheimer's Disease Macular Degeneration Neurological Disorders Parkinson Brain Cancer Degenerative Disease Medical Biotechnology Neurodegeneration Parkinson's Disease

Is ATH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.009
52 Week Low 0.003
Average Volume 13,393,443
200-Day Moving Average 0.006
50-Day Moving Average 0.005
20-Day Moving Average 0.004
10-Day Moving Average 0.004
Average True Range 0.001
RSI (14) 51.22
ADX 21.26
+DI 21.739
-DI 17.391
Chandelier Exit (Long, 3 ATRs) 0.003
Chandelier Exit (Short, 3 ATRs) 0.005
Upper Bollinger Bands 0.005
Lower Bollinger Band 0.003
Percent B (%b) 0.69
BandWidth 38.095
MACD Line 0.000
MACD Signal Line 0.000
MACD Histogram 0.0
Fundamentals Value
Market Cap 9.14 Million
Num Shares 2.03 Billion
EPS -0.02
Price-to-Earnings (P/E) Ratio -0.23
Price-to-Sales 735.64
Price-to-Book 9.09
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.005
Resistance 3 (R3) 0.005 0.005 0.005
Resistance 2 (R2) 0.005 0.005 0.005 0.005
Resistance 1 (R1) 0.005 0.005 0.005 0.005 0.005
Pivot Point 0.004 0.004 0.004 0.004 0.004
Support 1 (S1) 0.004 0.004 0.004 0.004 0.004
Support 2 (S2) 0.004 0.004 0.004 0.004
Support 3 (S3) 0.004 0.004 0.004
Support 4 (S4) 0.004